ABBV-085

ABBV-085 is an antibody drug conjugate (ADC) being investigated to treat advanced solid tumors.

Type of Molecule

Biologic

Target

LRRC15

Product Type

New Indication
Potential Indication Region Phase (1, 2, 3, Submitted, Approved)
Solid Tumors n/a
Phase 1